– Approval by Health Canada regulatory authority immediately clears the way for Pure Impact™ with PlyoPulse™ device launch and commercialization in Canada
– Canada Represents Another Substantial Market Opportunity for Sofwave’s Pure Impact™
SAN CLEMENTE, Calif., June 11, 2024 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced marketing clearance from Health Canada to commercialize Pure Impact™ utilizing PlyoPulse™ EMS (“Electric Muscle Stimulation”) technology in that region. Pure Impact™ with PlyoPulse™ technology, which is currently also approved and marketed in the U.S., was purposefully designed as a modular add-on component to the SUPERB™ system.
“The latest regulatory approval from Health Canada allows the Company to immediately initiate Sofwave’s second Pure Impact™ launch in North America. Pure Impact™ with PlyoPulse™ technology is the result of years of research and development and was developed in response to consumers’ growing demand for a cost-effective, non-invasive muscle toning treatment alternative to conventional plastic surgery,” noted Louis Scafuri, CEO of Sofwave Medical. “The U.S. Pure Impact™ product launch has been a major milestone this year for Sofwave, and we continue to seek additional approvals in other key markets for this highly innovative product. We are delighted to have this opportunity to offer a growing base of enthusiastic Canadian Sofwave practitioners an exciting, full body muscle toning solution and SUPERB™ product line extension, which we expect will further contribute to our growing base of recurring utilization revenues.”
About Pure Impact™ utilizing PlyoPulse™ EMS Technology:
Providers
Clinicians
Patients
According to McKinsey & Company’s latest medical aesthetic report the Canadian market in combination with the United States collectively hold an “outsized” share of the medical aesthetics market which rebounded immediately after COVID-19 and remains underpenetrated.
About Sofwave Medical
Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin) and neck tissue and the short-term improvement in the appearance of cellulite providing physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. Contact: Info@sofwave.com
Investor Contact:
Brian Ritchie
LifeSci Advisors LLC
(212) 915-2578
britchie@lifesciadvisors.com
To help improve clinician workflow and visualization during endoscopic bronchoscopy procedures, the company has added…
eClinicalWorks and the AI medical scribe assist the 126-provider health center in completing documentation at…
INDIANAPOLIS, Nov. 22, 2024 /PRNewswire/ -- Health centers across the state of Indiana have joined…
SHENZHEN, China, Nov. 22, 2024 /PRNewswire/ -- The 19th Annual Meeting of the International Conference…
CAMBRIDGE, Mass., Nov. 22, 2024 /PRNewswire/ -- SurgiBox, a pioneer in ultra-portable, inflatable surgical environments…
FORT WORTH, Texas, Nov. 22, 2024 /PRNewswire/ -- ESHA, Inc ("ESHA") provide certain revenue cycle…